
Avulux Added into the FDA-Funded Consortium for Technology & Innovation in Pediatrics (CTIP) Portfolio
Avulux, the innovator behind the only clinically proven lens that blocks the harmful light wavelengths linked to migraine attacks, today announced that the Consortium for